Webcast

June 18, 2009

Early Drug Development Strategies to Confirm Compound Viability and Increase Product Value for Promising CNS Candidates

Dr. Larry Ereshefsky - VP & Principal Consultant
Dr. Stan Jhee - Sr. Director Scientific Affairs

The webinar focuses on overcoming challenges in early drug development. How best practice application of the ‘CNS toolkit’ in early drug development can be used to confirm compound viability. Strategies that can increase the value of CNS compounds for divesture or improve investment potential.

Webcast length: 70 minutes

To view the webcast Click here